Copyright
©The Author(s) 2024.
World J Gastroenterol. Mar 14, 2024; 30(10): 1270-1279
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1270
Published online Mar 14, 2024. doi: 10.3748/wjg.v30.i10.1270
Indications | Contraindications |
CD | (1) Known or suspected intestinal strictures and/or fistulae (if patency not proven based on cross sectional imaging and/or patency capsule assessment[14]); (2) Magnetic resonance imaging examination scheduled for same-day or following days (requires prior confirmation of capsule excretion); and (3) Special conditions and relative contraindications: pregnancy; children under 8 yr of age; swallowing disorders; gastric surgery; implanted cardiac electric devices: Pacemakers, defibrillators, ventricular assist devices, telemetry; allergy or contraindications to any of the drugs or products used in the protocol; patients unable to walk for short periods and/or with neurological and/or psychiatric condition potentially favouring protocol deviations |
Inflammatory-type (non-stricturing, non-penetrating), extensive (affecting small bowel and colon) | |
Scheduled monitoring to evaluate mucosal healing in response to treatment (to justify and guide treatment change) | |
Evaluate disease distribution and severity: stratify patients to low vs high risk (prognosis); asymptomatic CD patients with abnormal analysis; exclude active CD or investigation of symptoms unrelated to disease activity | |
Establish diagnosis in patients with IBD-U, suspected CD or atypical ulcerative colitis | |
Gastrointestinal bleeding | |
Suspected mid-lower intestinal bleeding (overt or occult) |
- Citation: Rosa B, Cotter J. Capsule endoscopy and panendoscopy: A journey to the future of gastrointestinal endoscopy. World J Gastroenterol 2024; 30(10): 1270-1279
- URL: https://www.wjgnet.com/1007-9327/full/v30/i10/1270.htm
- DOI: https://dx.doi.org/10.3748/wjg.v30.i10.1270